Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients

Journal of Pharmacopuncture
Hassan AbolghasemiMohammad Gholami-Fesharaki

Abstract

This study compared the safety and efficacy of Safacto® versus xyntha® in patients with severe hemophilia A. Thirty-three male patients with severe hemophilia A were randomly divided into two groups. Seventeen patients received Safacto® and 16 patients received Xyntha® for four consecutive times. The dosage of FVIII was 40-50 IU/kg for each injection. Plasma level of FVIII activity was evaluated before every injection, 15 minutes after the injection and one month after the start of the trial. The rate of factor VIII activity, pain and joint motion were also assessed before and after the treatment. Plasma level of FVIII clotting activity in Safacto® and Xyntha® were 1.96±0.5 IU/dl and 1.63±0.5 IU/dl and increased to 88.84±25.2 IU/dl and 100.09±17.8 IU/dl, respectively (P<0.001). Pain score and range of motion improvement were 9.3±0.9 and 8.7±0.1 in Safacto® (P=0.17); and 9.4±0.8 and 8.8±0.3 in Xyntha® (P=0.35), respectively. No allergic or other unfavorable reactions was observed with either of the preparations. This study showed that Safacto® has a favorable efficacy and safety profile.

References

Jun 9, 2001·The New England Journal of Medicine·P M Mannucci, E G Tuddenham
Feb 1, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·J M LusherUNKNOWN ReFacto Phase 3 Study Group
Feb 9, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·E A ChalmersUNKNOWN Paediatric Working Party of UKHCDO
Feb 20, 2010·Seminars in Thrombosis and Hemostasis·Bert VerbruggenBritta A P Laros-van Gorkom
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Abdol Majid Cheraghali
Oct 3, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·M MorfiniA Iorio
Oct 26, 2014·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M FaranoushM Naderi
Jul 29, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·B NolanG Allen
May 26, 2016·The New England Journal of Medicine·Flora PeyvandiFrits R Rosendaal
Jun 25, 2016·Haemophilia : the Official Journal of the World Federation of Hemophilia·K SaxenaM Maas Enriquez
May 1, 2012·Value in Health Regional Issues·Abdol Majid Cheraghali, Peyman Eshghi

❮ Previous
Next ❯

Software Mentioned

SPSS
Xyntha

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

The New England Journal of Medicine
A Cohen, R Butler
Problemy gematologii i perelivaniia krovi
L P Papaian-Pokrysheva
Current Studies in Hematology and Blood Transfusion
Pier M MannucciM Cattaneo
© 2022 Meta ULC. All rights reserved